CDKN1A and breast cancer: In breast cancer, downregulation of c-Myc can promote senescence in breast cancer cells by activating Rb1/p21 [14], while in liver cancer, c-Myc can induce senescence in hepatocellular carcinoma cells by regulating telomerase activity [15].